Levalbuterol Tartrate Hfa Inhalation Aerosol, Metered
Product Images NDC 63187-876

9 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levalbuterol Tartrate Hfa Inhalation (NDC 63187-876). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Chemical Structure Levalbuterol Tartrate Is A Relatively Selective Beta2-adrenergic Receptor Agonist [see Clinical Pharmacology (12)]. Levalbuterol Tartrate Has The Chemical Name (r)-α1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol L-tartrate (2:1 Salt). (Levalbuterol Tartrate Hfa Inhalation 1)

The Following Chemical Structure Levalbuterol Tartrate Is A Relatively Selective Beta2-adrenergic Receptor Agonist [see Clinical Pharmacology (12)]. Levalbuterol Tartrate Has The Chemical Name (r)-α1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol L-tartrate (2:1 Salt). (Levalbuterol Tartrate Hfa Inhalation 1)
Chemical structure of levalbuterol tartrate, the active ingredient in Levalbuterol tartrate HFA inhalation aerosol. The structure shows two molecules of levalbuterol linked to tartrate.*
FDA Label Image

Figure 1 (Levalbuterol Tartrate Hfa Inhalation 2)

Figure 1 (Levalbuterol Tartrate Hfa Inhalation 2)
A line graph depicting the mean percentage change in FEV1 over 6 hours on Day 1 for three groups: Levalbuterol tartrate HFA Inhalation Aerosol (n=219), Racemic Albuterol HFA 180 mcg (n=119), and placebo (n=107). The graph shows time in hours on the x-axis and mean percentage change in FEV1 on the y-axis, illustrating relative lung function changes over time for these treatments.*
FDA Label Image

Figure 1 (Levalbuterol Tartrate Hfa Inhalation 3)

Figure 1 (Levalbuterol Tartrate Hfa Inhalation 3)
A line graph depicting mean percentage change in FEV1 (Forced Expiratory Volume in 1 second) over 6 hours on day 56. It compares three groups: Levalbuterol tartrate HFA inhalation aerosol, Racemic Albuterol HFA 180 mcg, and Placebo. The y-axis shows mean % change in FEV1, and the x-axis shows time in hours. The data shows the change trends for these treatments over time.*
FDA Label Image

Figure 1 (Levalbuterol Tartrate Hfa Inhalation 4)

Figure 1 (Levalbuterol Tartrate Hfa Inhalation 4)
An instructional diagram showing the parts of an inhaler device for Levalbuterol tartrate HFA inhalation. The labeled components include the canister, actuator, mouthpiece, and cap, illustrating how the parts fit together for proper use.*
FDA Label Image

Figure 2 (Levalbuterol Tartrate Hfa Inhalation 5)

Figure 2 (Levalbuterol Tartrate Hfa Inhalation 5)
An instructional illustration showing a hand holding a metered-dose inhaler in the mouthpiece-down position. The image labels the inhaler mouthpiece and the cap, demonstrating proper handling before use.*
FDA Label Image

Figure 3 (Levalbuterol Tartrate Hfa Inhalation 6)

Figure 3 (Levalbuterol Tartrate Hfa Inhalation 6)
An instructional line drawing showing a person holding and using a levalbuterol tartrate HFA metered-dose inhaler, placing the mouthpiece in the mouth for oral inhalation.*
FDA Label Image

Figure 4 (Levalbuterol Tartrate Hfa Inhalation 7)

Figure 4 (Levalbuterol Tartrate Hfa Inhalation 7)
An instructional illustration depicting a person holding and rinsing a Levalbuterol tartrate HFA inhaler canister under a running faucet. A spacer device with a mouthpiece and removable cap is shown next to the sink, suggesting steps for cleaning or preparing the inhaler for use.*
FDA Label Image

Figure 5 (Levalbuterol Tartrate Hfa Inhalation 8)

Figure 5 (Levalbuterol Tartrate Hfa Inhalation 8)
An instructional diagram showing two scenarios of using a metered-dose inhaler. The top illustration depicts the spray coming out normally labeled 'NOT CLOGGED.' The bottom illustration shows a weak or no spray from the inhaler labeled 'CLOGGED.' The images emphasize proper inhaler spray function.*
FDA Label Image

63187-876-15 (Levalbuterol Tartrate Hfa Inhalation 9)

63187-876-15 (Levalbuterol Tartrate Hfa Inhalation 9)
Label for Levalbuterol Tartrate HFA inhalation 45 mcg metered aerosol, 15g inhaler by Proficient Rx LP. The label states each actuation delivers 59 mcg of micronized levalbuterol tartrate equivalent to 45 mcg levalbuterol. Distributed by Actavis Pharma, Inc., Parsippany, NJ, USA. Storage instructions and safety warnings are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.